| Literature DB >> 32382213 |
Milad Haghani1, Michiel C J Bliemer1, Floris Goerlandt2, Jie Li3.
Abstract
The COVID-19 global pandemic has generated an abundance of research quickly following the outbreak. Within only a few months, more than a thousand studies on this topic have already appeared in the scientific literature. In this short review, we analyse the bibliometric aspects of these studies on a macro level, as well as those addressing Coronaviruses in general. Furthermore, through a scoping analysis of the literature on COVID-19, we identify the main safety-related dimensions that these studies have thus far addressed. Our findings show that across various research domains, and apart from the medical and clinical aspects such as the safety of vaccines and treatments, issues related to patient transport safety, occupational safety of healthcare professionals, biosafety of laboratories and facilities, social safety, food safety, and particularly mental/psychological health and domestic safety have thus far attracted most attention of the scientific community in relation to the COVID-19 pandemic. Our analysis also uncovers various potentially significant safety problems caused by this global health emergency which currently have attracted only limited scientific focus but may warrant more attention. These include matters such as cyber safety, economic safety, and supply-chain safety. These findings highlight why, from an academic research perspective, a holistic interdisciplinary approach and a collective scientific effort is required to help understand and mitigate the various safety impacts of this crisis whose implications reach far beyond the bio-medical risks. Such holistic safety-scientific understanding of the COVID-19 crisis can furthermore be instrumental to be better prepared for a future pandemic.Entities:
Keywords: 2019-nCov; COVID-19; Novel coronavirus; Safety
Year: 2020 PMID: 32382213 PMCID: PMC7203062 DOI: 10.1016/j.ssci.2020.104806
Source DB: PubMed Journal: Saf Sci ISSN: 0925-7535 Impact factor: 6.392
Summary statistics on scholarly publications related to Coronaviruses.
| No. | Authors | Count | Country/Regions | Count | Funding sponsors | Count | Institutes | Count | Subject areas | Count | Sources | Count |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Yuen, K.Y. | 168 | United States | 3878 | National Institutes of Health | 643 | The University of Hong Kong | 441 | Medicine | 5168 | Journal of Virology | 1005 |
| 2 | Enjuanes, L. | 164 | China | 2020 | National Natural Science Foundation of China | 360 | Chinese Academy of Sciences | 285 | Immunology and Microbiology | 4923 | Virology | 414 |
| 3 | Perlman, S. | 139 | United Kingdom | 890 | National Institute of Allergy and Infectious Diseases | 253 | Utrecht University | 284 | Biochemistry, Genetics and Molecular Biology | 2744 | Advances in Experimental Medicine and Biology | 365 |
| 4 | Drosten, C. | 133 | Germany | 823 | National Basic Research Program of China (973 Program) | 128 | National Institutes of Health, Bethesda | 220 | Agricultural and Biological Sciences | 1794 | Journal of General Virology | 278 |
| 5 | Rottier, P.J.M. | 121 | The Netherlands | 660 | European Commission | 110 | Centers for Disease Control and Prevention | 212 | Veterinary | 1587 | Archives of Virology | 192 |
| 6 | Baric, R.S. | 111 | China | 625 | Deutsche Forschungsgemeinschaft | 89 | The University of North Carolina at Chapel Hill | 190 | Pharmacology, Toxicology and Pharmaceutics | 572 | Emerging Infectious Diseases | 188 |
| 7 | Weiss, S.R. | 106 | Canada | 614 | U.S. Public Health Service | 64 | Departement Infectieziekten en Immunologie, Universiteit Utrecht | 178 | Multidisciplinary | 477 | Virus Research | 182 |
| 8 | Memish, Z.A. | 105 | France | 553 | Chinese Academy of Sciences | 57 | Chinese University of Hong Kong | 177 | Chemistry | 223 | Plos One | 175 |
| 9 | Holmes, K.V. | 102 | Japan | 482 | National Science Council | 55 | University of Iowa | 154 | Environmental Science | 201 | Journal of Medical Virology | 161 |
| 10 | Makino, S. | 91 | South Korea | 403 | National Multiple Sclerosis Society | 52 | CSIC - Centro Nacional de Biotecnologia CNB | 150 | Neuroscience | 174 | Veterinary Microbiology | 143 |
| 11 | Peiris, J.S.M. | 91 | Saudi Arabia | 394 | University of Hong Kong | 52 | Ministry of Health Saudi Arabia | 148 | Engineering | 112 | Journal of Virological Methods | 134 |
| 12 | Woo, P.C.Y. | 91 | Italy | 362 | U.S. Department of Agriculture | 48 | Faculteit Diergeneeskunde, Universiteit Utrecht | 144 | Mathematics | 97 | Viruses | 132 |
| 13 | Talbot, P.J. | 89 | Taiwan, China | 336 | Biotechnology and Biological Sciences Research Council | 43 | Queen Mary Hospital Hong Kong | 139 | Computer Science | 96 | Journal of Clinical Microbiology | 127 |
| 14 | Jiang, S. | 88 | Singapore | 309 | Wellcome Trust | 42 | Julius-Maximilians-Universität Würzburg | 136 | Chemical Engineering | 85 | Journal of Infectious Diseases | 115 |
| 15 | Saif, L.J. | 88 | Spain | 294 | National Research Foundation of Korea | 41 | Academy of Military Medical Science China | 135 | Physics and Astronomy | 75 | Proceedings of The National Academy of Sciences Of The United States Of America | 101 |
| 16 | Stohlman, S.A. | 88 | Switzerland | 270 | National Science Foundation | 40 | Erasmus MC | 134 | Social Sciences | 70 | American Journal of Veterinary Research | 100 |
| 17 | Snijder, E.J. | 87 | Australia | 269 | National Institute of General Medical Sciences | 38 | Keck School of Medicine of USC | 129 | Health Professions | 62 | Antiviral Research | 89 |
| 18 | Lau, S.K.P. | 84 | Brazil | 201 | Natural Sciences and Engineering Research Council of Canada | 37 | Leiden University Medical Center - LUMC | 122 | Materials Science | 55 | Journal of Clinical Virology | 80 |
| 19 | Lai, M.M.C. | 81 | Belgium | 154 | Canadian Institutes of Health Research | 36 | The Ohio State University | 120 | Nursing | 37 | Vaccine | 80 |
| 20 | Denison, M.R. | 76 | Sweden | 147 | Japan Society for the Promotion of Science | 35 | Chinese Academy of Medical Sciences & Peking Union Medical College | 120 | Arts and Humanities | 25 | Virology Journal | 79 |
Summary statistics on scholarly publications related to COVID-19.
| No. | Authors | Count | Country/Region | Count | Funding sponsors | Count | Institutes | Count | Subject areas | Count | Sources | Count |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Mahase, E. | 20 | China | 431 | National Natural Science Foundation of China | 71 | The University of Hong Kong | 37 | Medicine | 1029 | BMJ Clinical Research Ed | 99 |
| 2 | Rimmer, A. | 13 | United States | 222 | National Basic Research Program of China (973 Program) | 17 | Huazhong University of Science and Technology | 33 | Immunology and Microbiology | 191 | Lancet | 74 |
| 3 | Hsueh, P.R. | 10 | United Kingdom | 132 | National Institutes of Health | 11 | Tongji Medical College | 31 | Biochemistry, Genetics and Molecular Biology | 90 | Journal of Medical Virology | 47 |
| 4 | Jiang, S. | 8 | Italy | 67 | Fundamental Research Funds for the Central Universities | 10 | Chinese Academy of Sciences | 31 | Multidisciplinary | 53 | JAMA Journal of The American Medical Association | 34 |
| 5 | Memish, Z.A. | 8 | Canada | 48 | Chinese Academy of Sciences | 9 | Chinese Academy of Medical Sciences & Peking Union Medical College | 26 | Pharmacology, Toxicology and Pharmaceutics | 47 | BMJ | 31 |
| 6 | Rodriguez-Morales, A.J. | 8 | China | 45 | Wellcome Trust | 8 | School of Medicine | 26 | Social Sciences | 43 | Euro Surveillance Bulletin Europeen Sur Les Maladies Transmissibles European Communicable Disease Bulletin | 29 |
| 7 | Wiwanitkit, V. | 8 | France | 42 | Centers for Disease Control and Prevention | 6 | Capital Medical University | 25 | Environmental Science | 31 | Lancet Infectious Diseases | 29 |
| 8 | Zumla, A. | 8 | Singapore | 41 | Science and Technology Major Project of Guangxi | 6 | London School of Hygiene & Tropical Medicine | 25 | Neuroscience | 28 | Science | 25 |
| 9 | Kupferschmidt, K. | 7 | Germany | 39 | Bill and Melinda Gates Foundation | 5 | National University of Singapore | 24 | Health Professions | 25 | Travel Medicine and Infectious Disease | 25 |
| 10 | Sah, R. | 7 | Switzerland | 37 | Chinese Academy of Medical Sciences | 5 | Chinese University of Hong Kong | 23 | Nursing | 21 | Journal of Infection | 22 |
| 11 | Baden, L.R. | 6 | Australia | 34 | European and Developing Countries Clinical Trials Partnership | 5 | Fudan University | 23 | Psychology | 15 | Nature | 21 |
| 12 | Drosten, C. | 6 | India | 31 | Health and Medical Research Fund | 5 | Wuhan University | 23 | Veterinary | 15 | New England Journal of Medicine | 18 |
| 13 | Eurosurveillance Editorial Team | 6 | Taiwan, China | 28 | National Institute of Allergy and Infectious Diseases | 5 | The University of Hong Kong Li Ka Shing Faculty of Medicine | 21 | Agricultural and Biological Sciences | 14 | Emerging Microbes and Infections | 16 |
| 14 | Iacobucci, G. | 6 | South Korea | 26 | National Major Science and Technology Projects of China | 5 | Zhongnan Hospital of Wuhan University | 21 | Computer Science | 14 | Lancet Respiratory Medicine | 15 |
| 15 | Iacobucci, G. | 6 | Saudi Arabia | 25 | National Science Fund for Distinguished Young Scholars | 5 | Zhejiang University | 19 | Mathematics | 13 | Journal of Korean Medical Science | 13 |
| 16 | Ippolito, G. | 6 | Sweden | 17 | Sanming Project of Medicine in Shenzhen | 5 | UCL | 19 | Engineering | 12 | Infection Control and Hospital Epidemiology | 11 |
| 17 | Kim, J.Y. | 6 | Thailand | 17 | Agence Nationale de la Recherche | 4 | University of Oxford | 19 | Chemistry | 9 | International Journal of Infectious Diseases | 11 |
| 18 | Morrissey, S. | 6 | Brazil | 16 | Canadian Institutes of Health Research | 4 | Zhejiang University School of Medicine | 19 | Business, Management and Accounting | 5 | Journal of Hospital Infection | 11 |
| 19 | Rubin, E.J. | 6 | Japan | 15 | China Scholarship Council | 4 | Ministry of Education China | 18 | Chemical Engineering | 5 | Journal of Microbiology Immunology and Infection | 11 |
| 20 | Angeletti, S. | 5 | The Netherlands | 15 | Horizon 2020 Framework Programme | 4 | University of Toronto | 17 | Dentistry | 5 | Veterinary Record | 11 |
Studies on the safety-related aspects of the COVID-19 pandemic.
| No. | Reference | Safety dimension* | Method of study | Key message/finding | Key recommendations |
|---|---|---|---|---|---|
| 1 | Medical | Preliminary trials | Encouraging evidence for the effectiveness of chloroquine as COVID-19 treatment | N.A. | |
| 2 | Medicine | Limited clinical trials | Evidence that Hydroxychloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro | N.A. | |
| 3 | Medicine | Vaccine strategies related to SARS-CoV | Reviewing the previous SARS-CoV vaccine developments efforts | Multiple vaccine strategies need to be advanced quickly and then evaluated for safety and efficacy Safety studies to mitigate undesired risks will be the biggest time hindrance | |
| 4 | Medicine | Existing medical evidence and ongoing clinical trials | Reviewing efficacy and safety of chloroquine for COVID-19 treatment | There is enough evidence to justify clinical trials for chloroquine in patients with COVID-19 Urgent need for safety data and data from clinical trials | |
| 5 | Blood | Relevant publications on previous coronaviruses | There is a theoretical risk of transmission of coronaviruses through the transfusion of labile blood products | Discussing pathogen inactivation methods in Coronaviruses | |
| 6 | Blood | Relevant publications on previous coronaviruses | Public health messages are generally complied with even by those who do not trust the government Evaluating the possibilities of transfusion transmission in relation to COVID-19 | Outlining key questions in order to determine whether blood safety intervention is needed | |
| 7 | Pregnancy | Evidence from SARS and other Coronavirus Infections | Limited experience with Coronavirus infections during pregnancy Assessing the potential of the 2019-nCoV to cause maternal, fetal and neonatal morbidity | Recommendations for consideration of pregnant women in the design of clinical trials | |
| 8 | Pregnancy | Retrospective review of medical records | Limited data are available for pregnant women with COVID-19 pneumonia Evaluating clinical characteristics of COVID-19 in pregnancy and the potential for vertical transmission No neonatal asphyxia observed in newborn babies | Public health messages are generally complied with even by those who do not trust the government The similarity between clinical characteristics of COVID-19 pneumonia in pregnant women and those for non-pregnant adults No evidence of vertical transmission for women in late pregnancy | |
| 9 | Pregnancy | Evidence from similar pathogenic coronaviruses | Limited data available about coronavirus disease 2019 during pregnancy No evidence of in utero transmission observed in severe acute respiratory syndrome or Middle East respiratory syndrome | Coronavirus disease 2019 might increase the risk for pregnancy complications Outlining principles of management of COVID-19 in pregnancy | |
| 10 | Pregnancy | Synthesising the scientific literature | Reviewing clinical and psychological impacts of COVID-19 on perinatal women and their infants | Lack of enough scientific evidence on issues surrounding pregnancy and labouring | |
| 11 | Pregnancy, Surgery | Retrospective review of patients’ records | Excessive incidences of hypotension during epidural anesthesia for COVID-19 patients undergoing Caesarean | Evaluating safety and efficacy of different anesthetic regimens for COVID-19 patient during Cesarean delivery | |
| 12 | Surgery | Review of the literature and communication with physicians with firsthand experience of treating COVID-19 patients | Head and neck surgeons who come in close contact with the upper aerodigestive tract during diagnostic and therapeutic procedures are at high risk of contracting the disease | Safety recommendations for evaluation and surgery of head and neck for COVID-19 patients | |
| 13 | Pregnancy, Surgery | Medical practice experience in China | Anesthesia management in cesarean section for patients with coronavirus disease 2019 | Discussing protection of medical staff and psychological intervention for the patients during the operation | |
| 14 | Occupational | N.A. | Highlighting the role of companies and businesses in crisis management | A list of recommendations for companies to decrease the biological and psychological risk to their employees during the epidemic | |
| 15 | Occupational | Clinical practice in West China Hospital | Discussing clinical safety measures including patient screening, respiratory precautions and telemedicine consultations | The importance of having in place policies for infection control in every dermatology clinic | |
| 16 | Occupational | Clinal practice in Hong Kong | Aerosol generating procedures is a high-risk activity for healthcare professionals exposing them to contracting the infection | Outlining an approach for managing staff health risks during aerosol generating procedures | |
| 17 | Occupational | N.A. | The importance of the correct user of PPE by the GP’s | The correct use of PPE will help GPs balance between personal safety and appropriate levels of public concern | |
| 18 | Transport & visit | Evidence from randomised trials | Evaluating suitability of video consultation and the challenges involved Overall high patient satisfaction, no difference in disease progression and lower costs associated with video consultations | The need for revisiting these evaluations for patients with acute symptoms | |
| 19 | Transport & visit | Evidence from influenza pandemic | Highlighting potential breaches of infection control during episodes of patient transport outside isolation occur Outlining patient transport issues for COVID-19 | The importance of planning safe patient transport for suspected or confirmed cases Recommendations for inter-hospital and intra-hospital transfer of patients or suspected cases | |
| 20 | Laboratory, Occupational | N.A. | Reviewing precautionary and safety measures for radiology department personnel to manage patients with known or suspected COVID-19 infections | The need for implementation of robust plans by the radiology departments to prevent further transmission | |
| 21 | Laboratory | Laboratory tests | High infectivity and pathogenicity of SARS-CoV-2 pseudo-virus requires that it be handled in biosafety level 3 facilities, and this has hindered the development of anti-viral measures | Developing a series of pseudo-virus-based neutralisation assays and protocols for SARS-COV-2 which are safer and can be handled in biosafety level 2 facilities | |
| 22 | Food | N.A. | Highlighting the possibility of mass transmission during food packaging and preparedness | Recommendations for both producers and consumers on how to mitigate the risk infection through food | |
| 23 | Food | Epidemiological evidence related to SARS and COVID-19 outbreaks | Analysing the association of the SARS and COVID-19 outbreaks with wildlife diet in China | Suggestions for regulating wildlife conservation and food safety to prevent human exposure to novel viruses | |
| 24 | Social | N.A. | The importance of the Medicaid programs as a public social safety net in the US during the epidemic | A list of measures by which Medicaid programs can help reduce the spread of the virus and aid the healthcare system in the US | |
| 25 | Occupational, Mental | Evidence from previous epidemics | The importance of taking suicide prevention measures among healthcare professionals during the epidemic | Provision of adequate PPE, prior training, adequate sleep and nutrition could help mitigate the rate of suicide among doctors and nurses The benefits of maintaining healthcare reserve corps, or utilising the expertise of the military staff to mitigate the workload of clinicians The importance of maintaining shared social identity among healthcare professionals | |
| 26 | Mental | Survey the general public in China | More than half of respondents rated psychological impact of the outbreak as moderate to severe Female gender, student status and poor self-rated health associated with higher anxiety, depression and stress levels | N.A. | |
| 27 | Mental | Evidence from previous pandemics and public emergencies | Overwhelming and sensational news headlines and images add to public anxiety and fear Fear of the unknown elevates anxiety in healthy individuals and those with pre-existing mental conditions | The importance of providing mental support particularly for those who are most exposed to prevent adverse consequences such as suicide | |
| 28 | Mental | Analysis of social media feed (A Chinese microblogging website) | An increase in negative emotions and sensitivity to social risks and a decrease in scores of positive emotions and life satisfaction after the outbreak | The need for governments to plan to fight against the negative mental consequences of the outbreak | |
| 29 | Mental | N.A. | During self-isolation women living in rural areas are at a heightened risk of domestic violence Pandemic restrictions tend to aggravate family tensions | The need to promote strategies to protect women particularly in households with the history of family violence | |
| 30 | Mental | Evidence from a selection of research topics relevant to pandemics | Distancing could aggravate feelings of loneliness and cause long-term health consequences Stress caused by self-isolation could impact on the immune system Older adults who are at greater risk are also more susceptible to these effects | The importance of differentiating between loneliness and isolation The use of a better term such as “physical distancing” rather than “social distancing” The importance of maintaining social connectivity while keeping physically apart Cautioning against the passive use of social media | |
| 31 | Mental, Occupational | N.A. | The possible mental impact of moral injury on healthcare professionals Moral injury can potentially lead to depression, PTSD or even suicide | Listing several potential mechanisms that can help mitigate the negative impact of moral injury | |
| 32 | Mental | Evidence from previous outbreaks | Post-traumatic stress score could be significantly higher in children who were quarantined than children who were not | Considering the potential impact of prolonged school closure on children mental health Recommendations to mitigate mental health impact on children at the level of government, parents, schools and communities | |
| 33 | Mental | Survey of recommendations from WHO and the US Centre for Disease Control and Prevention | During the pandemic, fear increases anxiety level of healthy individuals and intensifies the symptoms of those with pre-existing psychiatric disorders | The need to implement public mental health policies along with clinical response strategies, during and after the crisis A list of mental health recommendations at the level of governments, individuals, social groups and medical facilities | |
| 34 | Mental | Public survey of Italian population sample | Public health messages are generally complied with even by those who do not trust the government Compliance slightly lower among young adults The quarantine restrictions have had serious mental impact | Public communication should focus on how people can cope better with home quarantine The need for behavioural interventions to help people cope better with the crisis |
*Medicine = “medicine, treatment and vaccine safety”, Blood = “blood safety”, Pregnancy = “pregnancy safety”, Surgery = “surgery and anesthetic safety”, Occupational = “occupational safety of healthcare workers”, Transport & visit = “patient transport and visit safety”, Laboratory = “biosafety of laboratories and facilities”, Food = “food safety”, Social = “Social public safety”, Mental = “mental/psychological health and domestic safety”.
Fig. 1Summary statistics on bibliographic details of the studies published on Coronaviruses and COVID-19. (a) The temporal distribution of the publications on Coronaviruses as well as their cumulative number of publications (data for 2020 only represents the first three months). Plots (b) and (c) show most published authors and journals on Coronaviruses respectively. Plots (d) and (e) show authors and journals with the highest number of publications on COVID-19 respectively. Plots (f) and (g) respectively show the top subject areas and top document types for publications on COVID-19.
Fig. 2Heat map of the sources that have published studies on (a) Coronaviruses and (b) COVID-19. In (a) and (b) the minimum number of documents of a journal to be visualised is respectively 20 and 5. The item weights are proportional to the number of documents published by each source.
Fig. 3The distribution of the geographical origin of the scholarly publications (a) on Coronaviruses, (b) on COVID-19.
Fig. 4Most frequent terms appeared in the title and abstract of the publications on COVID-19 based on the Scopus analyse search results.
Fig. 5The network of the hot terms associated with publications on (a) Coronaviruses and (b) COVID-19.
Fig. 6The heatmap of the network of the hot terms associated with publications on (a) Coronaviruses and (b) COVID-19.
Fig. 7The network of the hot terms associated with publications on Coronaviruses overlaid with a colour-coding of the average year of publications in which each term has appeared. The minimum number of occurrences for each term to be included in the map is 30 times.
Fig. 8Research dimensions related to the safety impact of the COVID-19 pandemic addressed by academic studies.